PAR-2 regulates dental pulp inflammation associated with caries

Journal of Dental Research

Volumn 89, Issue 7, 2010, Pages 684-688

  Lundy, F T ^a   About, I ^b   Curtis, T M ^a   McGahon, M K ^a   Linden, G J ^a   Irwin, C R ^a   El Karim, I A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Dental pulp; Human; Inflammation; PAR

Indexed keywords

AUTACOID; CALCIUM; CYCLOOXYGENASE 2; PROTEINASE ACTIVATED RECEPTOR 2; PTGS2 PROTEIN, HUMAN; TRYPSIN;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DENTAL CARIES; DRUG POTENTIATION; ENZYME ACTIVATION; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PULPITIS; WESTERN BLOTTING;

BLOTTING, WESTERN; CALCIUM; CELLS, CULTURED; CYCLOOXYGENASE 2; DENTAL CARIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; PULPITIS; RECEPTOR, PAR-2; TRYPSIN;

EID: 77953772578     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510365652     Document Type: Article

References (27)

1. Amadesi S., Bunnett N. (2004). Protease-activated receptors: protease signalling in the gastrointestinal tract. Curr Opin Pharmacol 4: 551-556.
2. Asano-Kato N., Fukagawa K., Okada N., Dogru M., Tsubota K., Fujishima H. (2005). Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. Invest Ophthal Vis Sci 46: 4622-4626.
3. Compton SJ, Renaux B., Wijesuriya SJ, Hollenberg MD (2001). Glycosylation and the activation of proteinase-activated receptor 2 (PAR-2) by human mast cell tryptase. Br J Pharmacol 134: 705-718.
4. DAndrea MR, Derian CK, Santulli RJ, Andrade-Gordon P. (2001). Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant tissues. Am J Pathol 158: 2031-2041.
5. Dale BA, Fredericks LP (2005). Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 7: 119-113.
6. El Karim IA, Lamey P. -J, Linden GJ, Lundy FT (2008). Neuropeptide Y Y1 receptor in human dental pulp samples of noncarious and carious teeth. Int Endod J 41: 850-855.
7. El Karim IA, Linden GJ, Irwin CR, Lundy FT (2009). Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts J Endod 35: 829-833.
8. Ferrell RW, Lockhart CJ, Plevin R. (2008). Protease-activated receptor-2 (PAR-2): a potential new target in arthritis. Drugs of the Future 33: 241-248.
9. Fiorucci S., Distrutti E. (2002). Role of PAR2 in pain and inflammation. Trends Pharmacol Sci 23: 153-155.
10. Gruber BL, Marchese MJ, Santiago-Schwarz F., Martin CA, Zhang J., Kew RR (2004). Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. J Invest Dermatol 123: 832-839.
11. Grynkiewicz G., Poenie M., Tsien RY (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
12. Hollenberg MD, Compton SJ (2002). International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54: 203-217.
13. Hollenberg MD, Compton SJ (2003). Proteinase-activated receptor domains and signalling. Drug Dev Res 59: 344-349.
14. Hyun E., Andrade-Gordon P., Steinhoff M., Vergnolle N. (2008). Protease-activated receptor-2 activation: a major factor in intestinal inflammation. Gut 57: 1222-1229.
15. Lourbakos A., Potempa J., Travis J., DAndrea MR, Andrade-Gordon P., Santulli R., et al. (2001). Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 69: 5121-5130.
16. Lundy FT, Linden GJ (2004). Neuropeptides and neurogenic mechanisms in oral and periodontal inflammation. Crit Rev Oral Biol Med 15: 82-98.
17. Macfarlane SR, Kanke T., Seatter M., Davenport E., Paul A., Plevin R. (2000). Trypsin stimulates the NF kappa B signalling pathway in NCTC 2544 transfected with human protease-activated receptor-2. Br J Pharmacol 129: 21P.
18. Macfarlane SR, Seatter MJ, Kanke T., Hunter GD, Plevin R. (2001). Proteinase-activated receptors. Pharmacol Rev 53: 245-282.
19. Morgan CR, Rodd HD, Clayton N., Boissonade FM (2009). Changes in proteinase-activated receptor 2 expression in the human tooth pulp in relation to caries and pain. J Orofac Pain 23: 265-274.
20. Patwardhan AM, Diogenes A., Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, et al. (2006). PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125: 114-124.
21. Scholfield CN, Curtis TM (2000). Heterogeneity in cytosolic calcium regulation among different microvascular smooth muscle cells of the rat retina. Microvasc Res 59: 233-242.
22. Shpacovitch V., Feld M., Bunnett NW, Steinhoff M. (2007). Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 28: 541-550.
23. Tancharoen S., Sarker KP, Imamura T., Biswas KK, Matsushita K., Tatsuyama S., et al. (2005). Neuropeptide release from dental pulp cells by RgpB via proteinase-activated receptor-2 signaling. J Immunol 174: 5796-5804.
24. Uehara A., Sugawara S., Muramoto K., Takada H. (2002). Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 169: 4594-4603.
25. Uehara A., Muramoto K., Takada H., Sugawara S. (2003). Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease activated receptor 2. J Immunol 170: 5690-5696.
26. Wang H., Wen S., Bunnett NW, Leduc R., Hollenberg MD, MacNaughton WK (2008). Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through 2-catenin and cyclic AMP-response element-binding protein. J Biol Chem 283: 809-815.
27. Xiang Y., Masuko-Hongo K., Sekine T., Nakamura H., Yudoh K., Nishioka K., et al. (2006). Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-12, TNF-±, and TGF-2. Osteoarthritis Cartilage 14: 1163-1173.